Election day is upon us and it appears that both SPACs and de-SPACs lined up their business for just before the polls rather than during or after. More
NorthStrive I (NASDAQ:NSAI) has entered into a definitive agreement to combine with nuclear technology firm Nuclea Energy at an enterprise value of $350 million. Mississauga, Canada-based Nuclea is developing molten salt nuclear reactor designs that would be modular and scalable from 3. More
Starlink AI (NYSE:OTAI) has entered into a definitive agreement to combine with crypto mining firm Spider Digital at a $250 million valuation. Singapore-based Spider Digital provides pooled crypto mining resources and tools for miners and crypto financiers. More
FG Imperii (NASDAQ:FGII) has entered into a definitive agreement to combine with digital asset firm tZERO at a pro forma enterprise value of $409 million. tZERO provides a platform for tokenizing real world assets and other financial products. More
October 2026 brought another active month for SPAC corporate actions, with extension votes accounting for a significant portion of activity and new merger announcements continuing at a steady pace. Completion activity included several shareholder approvals and business combination closings, while IPO issuance slowed from the stronger pace seen earlier in the year. More
Terms Tracker for the Week Ending October 30, 2026 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week's pricings. The SPAC market still remains sluggish and ended October with an IPO count of six, which is only one more than September's count of five. More
Five SPAC sponsors and four sets of company investors are set to be freed up from trading restrictions in the coming month, but the current volatility may dissuade them from acting immediately on this. More
Redwoods II has filed for a $75 million SPAC with an Asia-based team focused on the energy storage, telecom and consumer sectors. The new SPAC is offering investors one full warrant and one right to a 1/4 share, which is notably generous, but this has also been roughly the going rate for this corner of the market lately. More
Biotech is big in the world of SPACs once again. Half of the SPACs that have managed to IPO in the second half of October are specifically targeting the industry and three biotech deals have been announced since the start of the month. More
Another SPAC has made it through the IPO slowdown, but its team has once again made some considerable concessions to get it done. In the case of BHAV II (NASDAQ:BHAIU), the sponsor only overfunded its trust to 100. More